Parsortix system pivotal in novel cancer treatment trial
LONDON - ANGLE plc, a leading liquid biopsy company, has announced a significant development in cancer treatment strategy, ...
Healio55m
‘Potential gamechanger’: Researchers discover basis for immunotherapy-induced myocarditis
Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...